These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23757624)

  • 1. Osteoporosis in men.
    Watts NB
    Endocr Pract; 2013; 19(5):834-8. PubMed ID: 23757624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in men: what has changed?
    Adler RA
    Curr Osteoporos Rep; 2011 Mar; 9(1):31-5. PubMed ID: 21113693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.
    Ringe JD; Faber H; Farahmand P; Dorst A
    Rheumatol Int; 2006 Mar; 26(5):427-31. PubMed ID: 16001181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications and Outcomes of Osteoporosis and Bone Modulation Therapies.
    Weinerman S; Usera GL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):567-71. PubMed ID: 26363939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating osteoporosis to prevent fractures: current concepts and future developments.
    Lorentzon M
    J Intern Med; 2019 Apr; 285(4):381-394. PubMed ID: 30657216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Male osteoporosis].
    Farahmand P; Spiegel R; Ringe JD
    Z Rheumatol; 2016 Jun; 75(5):459-65. PubMed ID: 27117306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary osteoporosis in men.
    Giusti A; Bianchi G
    Clin Interv Aging; 2015; 10():105-15. PubMed ID: 25565793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.
    Schousboe JT; Taylor BC; Fink HA; Kane RL; Cummings SR; Orwoll ES; Melton LJ; Bauer DC; Ensrud KE
    JAMA; 2007 Aug; 298(6):629-37. PubMed ID: 17684185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis in men: epidemiology and treatment with denosumab.
    Sidlauskas KM; Sutton EE; Biddle MA
    Clin Interv Aging; 2014; 9():593-601. PubMed ID: 24748777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Practice. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 Jan; 374(3):254-62. PubMed ID: 26789873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal.
    Marques A; Lourenço Ó; Ortsäter G; Borgström F; Kanis JA; da Silva JA
    Calcif Tissue Int; 2016 Aug; 99(2):131-41. PubMed ID: 27016370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriparatide in the treatment of osteoporosis.
    Stroup J; Kane MP; Abu-Baker AM
    Am J Health Syst Pharm; 2008 Mar; 65(6):532-9. PubMed ID: 18319498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Good and the Bad About the 2017 American College of Physicians Osteoporosis Guidelines.
    Lagari V; Gavcovich T; Levis S
    Clin Ther; 2018 Jan; 40(1):168-176. PubMed ID: 29196083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.